CLINICAL SCIENCE
Recombinant factor VIIA is associated with an improved 24-hour survival without an improvement in inpatient survival in massively transfused civilian trauma patients
Bartolomeu NascimentoI,
, Yulia LinII, Jeannie CallumII, Marciano ReisII, Ruxandra PintoI, Sandro RizoliI
Corresponding author
I Tory Regional Trauma Centre, Sunnybrook Health Sciences Centre, Departments of Surgery, University of Toronto, Canada; Sunnybrook Health Sciences Centre, Departments of Critical Care & Clinical Pathology, University of Toronto, Canada.
II Sunnybrook Health Sciences Centre, Department of Clinical Pathology, University of Toronto, Canada, Toronto, ON, Canada.
Read
563
Timeswas read the article
212
Total PDF
351
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 July | 15 | 15 | 30 |
| 2024 June | 12 | 14 | 26 |
| 2024 May | 14 | 11 | 25 |
| 2024 April | 20 | 8 | 28 |
| 2024 March | 10 | 12 | 22 |
| 2024 February | 13 | 9 | 22 |
| 2024 January | 27 | 16 | 43 |
| 2023 December | 22 | 17 | 39 |
| 2023 November | 9 | 17 | 26 |
| 2023 October | 11 | 21 | 32 |
| 2023 September | 18 | 24 | 42 |
| 2023 August | 10 | 2 | 12 |
| 2023 July | 22 | 22 | 44 |
| 2023 June | 15 | 10 | 25 |
| 2023 May | 34 | 3 | 37 |
| 2023 April | 34 | 0 | 34 |
| 2023 March | 30 | 4 | 34 |
| 2023 February | 17 | 2 | 19 |
| 2023 January | 3 | 2 | 5 |
| 2022 December | 15 | 3 | 18 |
Show all